Senate Health Committee Approves FDA Nominee

Chairman Lamar Alexander (R-Tenn.) made the following statement on the Senate health committee’s approval of Dr. Robert Califf to head the Food and Drug Administration (FDA)

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Chairman Lamar Alexander (R-Tenn.) made the following statement on the Senate health committee’s approval of Dr. Robert Califf to head the Food and Drug Administration (FDA):

“The FDA affects the lives of nearly every single American and regulates about a quarter of all consumer spending in the United States—over $4 trillion annually. Americans need competent leadership to head this significant agency and to help bring safe drugs and devices to market faster and protect our nation’s food supply. The Senate should consider Dr. Califf’s nomination quickly to fill this important role.”
The Senate health committee held a hearing on Nov. 17 to consider Dr. Califf’s nomination. Click here for Chairman Alexander’s remarks at that hearing.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground